CAS 1021106-40-0

N-(4-Chlorobenzyl)-N-(2-(indolin-1-yl)-2-oxoethyl)pyridine-3-sulfonamide

CAS : 1021106-40-0

N-(4-Chlorobenzyl)-N-(2-(indolin-1-yl)-2-oxoethyl)pyridine-3-sulfonamide

Degré de pureté : 98%

Masse moléculaire : 441.94g/mol

Ref: 54-OR1073786

IXA6

CAS : 1021106-40-0

IXA6 is a protein-based analog that has been shown to have potent anticancer properties. It works by inhibiting the activity of kinases, which are enzymes that play a crucial role in cell cycle regulation and proliferation. IXA6 has been found to induce apoptosis, or programmed cell death, in cancer cells. This medicinal compound has been extensively studied in Chinese hamster ovary (CHO) cells and human urine, and it has demonstrated significant tumor growth inhibition in various cancer cell lines. IXA6 is a promising candidate for the development of novel cancer therapies due to its potent inhibitor activity against tumor growth and its ability to induce apoptosis.

Formule : C₂₂H₂₀ClN₃O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 441.9 g/mol

Ref: 3D-WQB10640

IXA6

CAS : 1021106-40-0

IXA6 is an IRE1/XBP1s agonist with potential vasoprotective activity for the study of neurodegenerative diseases such as Parkinson's disease.

Formule : C₂₂H₂₀ClN₃O₃S

Degré de pureté : 98.63%

Couleur et forme : Solid

Masse moléculaire : 441.93

Ref: TM-T62568